23 March 2020

CORONAVIRUS - DiaSorin COVID-19 test has received FDA Emergency Use Authorization

DiaSorin Molecular LLC, a division of DiaSorin S.p.A. announced that it has received Emergency Use Authorization (EUA) from the FDA for their Simplexa™ COVID-19 Direct kit.
22 March 2020

AGC Inc. announces the launch of a voluntary tender offer over all ordinary shares of MolMed S.p.A.

MolMed announced that AGC Inc. declared its intention to launch a voluntary tender offer over 100% of the Company's ordinary shares
21 March 2020

CORONAVIRUS - Takis announces that it is ready to test its Covid-19 vaccine on pre-clinical models

The authorization comes from the Ministry of Health and represents the first step in bringing the vaccine to human use. Takis researchers are the only ones in Italy and the first in Europe to access this phase of the experimentation.
10 March 2020

CORONAVIRUS - DiaSorin has completed the studies to support the launch by the end of march 2020 of a rapid response molecular diagnostic test for the COVID-19

DiaSorin announced that it has completed at the Spallanzani Hospital in Rome and at the Policlinico San Matteo in Pavia, the studies necessary to support the CE marking and FDA EUA submission of an innovative molecular test for the rapid identification of the novel coronavirus COVID-19.
09 March 2020

MolMed announces a new collaboration in the field of T cell therapies

MolMed announces the execution of a development and supply agreement with Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer
03 March 2020

CORONAVIRUS - Applied DNA Sciences updates on COVID-19 collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine candidates designed

Applied DNA Sciences Inc. and Takis Biotech announced that the design of 4 DNA vaccine candidates that will be produced for preclinical animal testing via the Company’s proprietary PCR-based DNA manufacturing systems

Partner

Where to find us

20149 Milan
Via Giovanni da Procida, 11
Show map 
Tel. +39 02.34565.1
Fax. +39 02.34565.310
Segreteria Assobiotec
Tel. 02 34565.256/341
assobiotec@federchimica.it